Study Evaluating the Effects of MOA-728 on Cardiac Repolarization in Healthy Subjects

Phase 1CompletedNCT00434395

Bausch Health Americas, Inc.

Overview

The purpose of the study is to assess the effects of MOA-728 on cardiac repolarization in healthy subjects.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Conditions

Healthy

Interventions

MOA-728DRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 50 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Generally healthy subjects men or women aged 18-50 Exclusion Criteria: * Any significant clinically important disease * Family history of long QT syndrome and/or sudden cardiac death * Allergy to moxifloxacin or the quinolone class of antibiotics

Locations (1)

Unnamed facility

Phoenix, Arizona, United States

Outcomes

Primary Outcomes

Cardiac repolarization will be assessed by the QTc interval in healthy subjects.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.